Showing results (91-100 of 113) with videos related to

Sort By:
Pageof 12
Cancer Research|August 18, 2018
CD44-Targeting PLGA Nanoparticles Incorporating Paclitaxel and FAK siRNA Overcome Chemoresistance in Epithelial Ovarian CancerYeongseon Byeon, Jeong-Won Lee, Whan Soo Choi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 24, 2009
c-Jun-NH2-kinase-1 inhibition leads to antitumor activity in ovarian cancerPablo Vivas-Mejia, Juliana Maria Benito, Ariel Fernandez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 18, 2014
Biologic effects of platelet-derived growth factor receptor α blockade in uterine cancerJu-Won Roh, Jie Huang, Wei Hu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 4, 2014
Cross-talk between EphA2 and BRaf/CRaf is a key determinant of response to DasatinibJie Huang, Wei Hu, Justin Bottsford-Miller, et al.
Cancer Research|May 1, 2010
Sustained small interfering RNA delivery by mesoporous silicon particlesTakemi Tanaka, Lingegowda S Mangala, Pablo E Vivas-Mejia, et al.
Neoplasia (New York, N.Y.)|May 2, 2013
Biologic effects of dopamine on tumor vasculature in ovarian carcinomaMyrthala Moreno-Smith, Sun Joo Lee, Chunhua Lu, et al.
Cancer Discovery|September 5, 2013
Therapeutic synergy between microRNA and siRNA in ovarian cancer treatmentMasato Nishimura, Eun-Jung Jung, Maitri Y Shah, et al.
Neoplasia (New York, N.Y.)|April 8, 2011
Targeted delivery of small interfering RNA using reconstituted high-density lipoprotein nanoparticlesMian M K Shahzad, Lingegowda S Mangala, Hee Dong Han, et al.
Cancer Research|April 19, 2014
Notch3 pathway alterations in ovarian cancerWei Hu, Tao Liu, Cristina Ivan, et al.
Pageof 12